BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/3265 |
Resumo: | The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation. |
id |
RCAP_a0acea46b42d29907717364b011e211b |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/3265 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa InfectionCHLC CPRCHLC PAT CLINAnimalsAnti-Bacterial Agents / metabolismAnti-Bacterial Agents / therapeutic useDisease Models, AnimalGenetic TherapyGenetic Vectors / therapeutic useGenetic Vectors / geneticsGraft SurvivalIschemia / complicationsPseudomonas Infections / complicationsMalePseudomonas Infections / therapyPseudomonas aeruginosa / drug effectsRatsRats, WistarSkin Transplantation / adverse effectsSurgical Flaps / adverse effectsSurgical Flaps / microbiologyTransduction, Geneticbeta-Defensins / geneticsbeta-Defensins / therapeutic useThe main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation.Nature Publishing GroupRepositório do Centro Hospitalar Universitário de Lisboa Central, EPECasal, DIria, IRamalho, JSAlves, SMota-Silva, EMascarenhas-Lemos, LPontinha, CGuadalupe-Cabral, MFerreira-Silva, JFerraz-Oliveira, MVassilenko, VGoyri-O'Neill, JPais, DVideira, P2019-05-30T11:43:58Z2019-05-272019-05-27T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3265engSci Rep. 2019 May 27;9(1):7854.10.1038/s41598-019-44153-yinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:42:08Zoai:repositorio.chlc.min-saude.pt:10400.17/3265Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:35.420628Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
title |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
spellingShingle |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection Casal, D CHLC CPR CHLC PAT CLIN Animals Anti-Bacterial Agents / metabolism Anti-Bacterial Agents / therapeutic use Disease Models, Animal Genetic Therapy Genetic Vectors / therapeutic use Genetic Vectors / genetics Graft Survival Ischemia / complications Pseudomonas Infections / complications Male Pseudomonas Infections / therapy Pseudomonas aeruginosa / drug effects Rats Rats, Wistar Skin Transplantation / adverse effects Surgical Flaps / adverse effects Surgical Flaps / microbiology Transduction, Genetic beta-Defensins / genetics beta-Defensins / therapeutic use |
title_short |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
title_full |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
title_fullStr |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
title_full_unstemmed |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
title_sort |
BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection |
author |
Casal, D |
author_facet |
Casal, D Iria, I Ramalho, JS Alves, S Mota-Silva, E Mascarenhas-Lemos, L Pontinha, C Guadalupe-Cabral, M Ferreira-Silva, J Ferraz-Oliveira, M Vassilenko, V Goyri-O'Neill, J Pais, D Videira, P |
author_role |
author |
author2 |
Iria, I Ramalho, JS Alves, S Mota-Silva, E Mascarenhas-Lemos, L Pontinha, C Guadalupe-Cabral, M Ferreira-Silva, J Ferraz-Oliveira, M Vassilenko, V Goyri-O'Neill, J Pais, D Videira, P |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Casal, D Iria, I Ramalho, JS Alves, S Mota-Silva, E Mascarenhas-Lemos, L Pontinha, C Guadalupe-Cabral, M Ferreira-Silva, J Ferraz-Oliveira, M Vassilenko, V Goyri-O'Neill, J Pais, D Videira, P |
dc.subject.por.fl_str_mv |
CHLC CPR CHLC PAT CLIN Animals Anti-Bacterial Agents / metabolism Anti-Bacterial Agents / therapeutic use Disease Models, Animal Genetic Therapy Genetic Vectors / therapeutic use Genetic Vectors / genetics Graft Survival Ischemia / complications Pseudomonas Infections / complications Male Pseudomonas Infections / therapy Pseudomonas aeruginosa / drug effects Rats Rats, Wistar Skin Transplantation / adverse effects Surgical Flaps / adverse effects Surgical Flaps / microbiology Transduction, Genetic beta-Defensins / genetics beta-Defensins / therapeutic use |
topic |
CHLC CPR CHLC PAT CLIN Animals Anti-Bacterial Agents / metabolism Anti-Bacterial Agents / therapeutic use Disease Models, Animal Genetic Therapy Genetic Vectors / therapeutic use Genetic Vectors / genetics Graft Survival Ischemia / complications Pseudomonas Infections / complications Male Pseudomonas Infections / therapy Pseudomonas aeruginosa / drug effects Rats Rats, Wistar Skin Transplantation / adverse effects Surgical Flaps / adverse effects Surgical Flaps / microbiology Transduction, Genetic beta-Defensins / genetics beta-Defensins / therapeutic use |
description |
The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05-30T11:43:58Z 2019-05-27 2019-05-27T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/3265 |
url |
http://hdl.handle.net/10400.17/3265 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Sci Rep. 2019 May 27;9(1):7854. 10.1038/s41598-019-44153-y |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131301850120192 |